Introduction
Hepatocellular carcinoma (HCC) is the most common primary malignant cancer of the liver with high rates of lethality in the world (Lope et al; . It is the fifth most common cancer worldwide and the third leading cause of death from cancer in the world, with resistance to chemotherapy and poor prognosis (Yao et al; ). It is as an epithelial tumor that is originated from stem cells or mature hepatocytes (Malenstein et al; . The major risk factors of HCC are viral hepatitis infection, chronic alcohol consumption, fungal toxins (aflatoxins), nonalcoholic fatty liver disease (NAFLD), hemochromatosis and steroid hormone (Yang et al., 2010 , Gavilán et al., 2013 . HCC occurs commonly and with increasing frequency in developing countries
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DNA methylation as an alternative mechanism leads to a decrease in expression of miR-34 family in a variety of cancers such as colorectal cancer, ovarian cancers, oral cancer and malignant pleural mesothelioma (Kozaki et al., 2008 , Corney et al., 2010 , Kalimutho et al., 2011 , Kuboet al., 2011 . Several evidences have shown that populations with greater reliance on spices, vegetables and fruits in the diet experience lower risk for cancers. Many of the herbal sources, currently used to treat cancer or other diseases, are naturally multi targeting, safer, inexpensive and immediately available (Gupta et al; . Curcumin is a biphenyl compound derived from rhizome of Curcuma longa and commonly called turmeric. It has excellent antioxidant, anti-inflammatory and anti-tumorigenic properties (Altunbas et al; . However, the significant therapeutic properties of cur have been hindered by its low bioavailability.
Numerous approaches including the use of liposomes, nanoparticles, micelles, adjuvants and phospholipid complexes have been explored to increase the bioavailability of Cur (Anand et l; 2007) . Here, we employed dendrosome nanoparticles to increase the bioavailability and solubility of this agent in comparison with other carriers such as micelles, liposomes and phospholipids. Dendrosome nanoparticles, previously synthesized by our group 2008) have several advantages such as stability, electrically neutral, biodegradability, spherical structure, non-toxic and easy preparation. Previous studies by our group have shown that dendrosomal nano curcumin (DNC) increase uptake of curcumin into cancer cells without any toxic effects on normal cells (Babaei et al., 2012 , Tahmasebi Mirgani et al., 2014 . Therefore, the aim of the current study is to test the gene expression levels of miR-34 family members and DNMTs in Huh7 and HepG2 cells following treatment with DNC.
Materials and Methods

DNC preparation
To provide the DNC, curcumin powder (Purchased from Sigma-Aldrich Company,USA) and nano-carrier (a gift from Institute of Biochemistry and Biophysics, University of Tehran, Iran ) based on optimized protocols as described in the previous findings (Babaei et al., 2012 , Tahmasebi Mirgani et al., 2014 , were combined together. To provide the appropriate concentration of DNC, it is diluted with Phosphate buffered saline (PBS) and stored in refrigerator.
Cell lines and culture condition
In this study, two cancer cell lines including Huh7 and HepG2 cells (from Pasteur Institute, Tehran, Iran) were cultured in Dulbecco's modified Eagle's medium (DMEM; GIBCO®, USA) with 10% fetal bovine serum (FBS; GIBCO®, USA),100 U/ml penicillin and 100 mg/ml streptomycin (LifeTechnologies). All cells were incubated at 37 ° C and 5% carbon dioxide.
Cell viability test
Cell viability is used for drug screening and cytotoxicity tests of chemicals. This was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay according to the manufacturer's instructions (Sigma-Aldrich,USA). Briefly, identical numbers of hepatoma cells were seeded in 96-well plates triplicate in a final volume of 200μl medium with 10% FBS and incubated overnight at 37 ° C and 5% CO2. Huh7 and HepG2 cell lines were treated with varying concentrations of DNC for 24h and 48h. A complete culture medium without cells was used as a blank. After removing the medium of each well, 20μl of MTT (5mg/ ml) was added to each well and plates were incubated 
Semi quantitative reverse transcription PCR (sqRT-PCR)
After reverse transcription reaction in order to ensure the accuracy and specificity of the primers, reverse transcription PCR reaction was performed on the RT product. PCR was done using Maste Mix (Ampliqon, Denmark) at the following conditions: denaturation at 94 ° C for 30 seconds in a cycle and annealing at 60 ° C for 30 seconds in 35 cycles. PCR products were separated on 2% agarose gel electrophoresis and were observed by using ultraviolet rays after staining with ethidium bromide.
Real-Time quantitative reverse transcription-PCR (Real-Time qRT-PCR)
Real-time PCR was performed using the SYBR® Premix Ex Taq TM II (Takara Bio Inc.,Shiga,Japan). The relative amount of DNMTs gene expression levels were normalized to the expression of GAPDH as house-keeping gene. Relative gene expression was calculated using the comparative cycle threshold (RQ=2 -ΔΔCT) method.
MiRNA expression analysis
RNA was extracted from either control or treated group using TRIzol® reagent (Life Technologies). Due to the small size of the microRNA, a poly A nucleotide tail was added to the miRNAs using polyA polymerase. In the reverse transcription step, cDNA is reverse transcribed using specific reverse primers and reverse transcriptase enzyme using MiR-Amp kit (Pars Genome,Tehran,Iran), according to the manufacturer's instruction. In the PCR step, PCR products are amplified from cDNA samples using 5× HOT FIRE POL® EvaGreen® qPCR Mixplus ROX (Solis Bio Dyne,Tartu,Estonia) kit. The expressions for another 4h. Then the supernatant was removed and the insoluble formazan crystals were dissolved in 200μl of dimethyl sulfoxide (DMSO). The absorbance intensity was measured at 570nm by a 96-well plate reader (TECAN, Switzerland). The results were expressed as percentage of cell viability against the untreated control cells. Afterwards, 50% inhibitory concentrations (IC50) that means concentration where half of the cells were alive, were calculated by standard curve method.
RNA extraction and reverse transcription
According to the amount of IC50 obtained from MTT assay, Huh7 and HepG2 cell lines were treated with DNC. After 24 h and 48 h incubation, total RNA was extracted from each group with TRIzol®reagent (Life Technologies). RNA quantity was analyzed using NanoDrop 1,000 (Thermo, USA). To verify the RNA quality, the existence of 18s, 28s and 5s were analyzed on agarose gel. Complementary DNA (cDNA) was synthesized by PrimeScriptTMRT reagent kit (Takara Bio Inc,Shiga, Japan). Primers sequence for house keeping gene glyceraldehyde3-phosphatedehydrogenase (GAPDH) and DNMT1, DNMT3A and DNMT3B genes are indicated in Table1. of miR-34a, miR-34b, miR-34c and U6 (reference gene) were analyzed using universal and specific primer sets MiR-Amp kit (ParsGenome,Tehran,Iran). Relative gene expression was calculated using the comparative cycle threshold (RQ=2 -ΔΔCT) method.
Statistical analysis
All statistical analyses were performed using Prism®5 software (Graph Pad Soft-ware, Inc., LaJolla, CA, USA) and Microsoft Excel. Data were presented in one way analysis of variance followed by Newman-Keuls multiple comparison test or Student's t-test to compare expression between two group. The P<0.05 was considered statistically significant.
Results
Curcumin inhibit hepatoma cancer cell proliferation
The cytotoxic effect of DNC on HepG2 and HuH-7 cell lines could be seen microscopically as vesicular bodies in DNC treated cells in Figure 1 b and d compared to control ones in Fig.1 a and c . We also performed a MTT assay to study the effects of curcumin on the proliferation of Huh7 and HepG2 hepatoma cell lines. These cell lines were treated with multiple concentrations of curcumin for either 24h or 48h. As shown in Figure 2a in hepatoma cell lines Figure 3 . DNC up-Regulates miR-34a, miR-34b and miR-34c in Hepatoma Cell Lines .a) miR-34a b) miR-34b and c) miR-34c in HepG2, d) miR-34a e) miR-34b and f) miR-34c in Huh7. Bars Represent Mean and Standard Error of Three Independent Experiments. Control: Non-Treated Sample, ns: Non Significant, *P<0.05, ** P<0.01. To investigate the effect of DNC on miR-34 family expression, Huh7 and HepG2 cell lines were treated with DNC after 24h and 48h and alterations in the genes expression of miR-34 family were evaluated by Real-Time qRT-PCR as shown in Fig3. Our current data demonstrated that DNC significantly induced the expression of miR-34a, miR-34b and miR-34c relative quantification to reference gene U6 both Huh7 and HepG2 (P<0.05).
Dendrosomal nanocurcumin down-regulates DNMTs in hepatoma cell lines
Huh7 and HepG2 cell lines were treated with DNC for 24h and 48h then the alterations in the genes expression of DNMTs and GAPDH were evaluated by Real-Time qRT-PCR (Fig4). Our current data demonstrated that DNC significantly,reduced the expression of DNMT1, DNMT3A and DNMT3B relative quantification to reference gene GAPDH both Huh7 and HepG2 (P<0.05).
Discussion
Bioactive nutrients including curcumin (a biphenyl compound derived from rhizome) offer great potential in causing cancerous cell death. In current study, using MTT assay, we indicated that HCC cells lines treated with DNC showed a time and dose dependent reduced viability compared with untreated cells. We used DNC with higher bioavalibility compared to curcumin. The dendrosomes were shown to be safe for entrance of curcumin to cancer cells and only DNC leads to death of cancer cells and dendrosome has facilitated delivery of curcumin to cancer cells (Babaei et al; 2012, Tahmasebi Mirgani et al; 2014, Zamani et al; .
The miR-34 family members including mir34a, mir34b and mir34c acts as tumor suppressor microRNAs. Hence, their reduction or loss of expression was reported in a large number of tumors including breast, colorectal, melanoma and HCC (Gopalan et al; 2014, Li et al; . However, no studies have been performed to determine whether miR-34 family could be re-expressed in hepatoma cancer by DNC. We found that DNC upregulated mir34a, mir34b and mir34c expression (P<0.05) in both HepG2 and Huh7 cell lines. We indicated that these upreulation is the result of DNMTs down-regulation.
Our previous work showed that DNC could induce the apoptosis of cancer cells by down-regulation of DNMTs expression following the overexpress of tumor suppressor genes (Babaei et al; 2012, Tahmasebi Mirgani et al; 2014, Zamani et al; .
In conclusion, we provide evidence that administration of DNC inhibits proliferation of HCC cells through increasing the expression of miR-34a, miR-34b and miR-34c.
Furthermore, our findings demonstrate that the expression of DNMT1, DNMT3A and DNMT3B is greatly down-regulated under treated with DNC, suggesting that DNC restores the expression of mir-34 family members via down-regulation of these enzymes. These findings suggest that DNC potentially could be used in clinic especially for HCC therapy.
